M. TURKELI Et Al. , "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.," Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.985-9, 2015
TURKELI, M. Et Al. 2015. Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.. Asian Pacific journal of cancer prevention : APJCP , vol.16 , 985-9.
TURKELI, M., Aldemir, M. N., CAYIR, K., SIMSEK, M., BILICI, M., TEKIN, S., ... YILDIRIM, N.(2015). Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.. Asian Pacific journal of cancer prevention : APJCP , vol.16, 985-9.
TURKELI, M Et Al. "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.," Asian Pacific journal of cancer prevention : APJCP , vol.16, 985-9, 2015
TURKELI, M Et Al. "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.." Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.985-9, 2015
TURKELI, M. Et Al. (2015) . "Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.." Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.985-9.
@article{article, author={M TURKELI Et Al. }, title={Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.}, journal={Asian Pacific journal of cancer prevention : APJCP}, year=2015, pages={985-9} }